Skip to main content
Clinical Trials/IRCT20230722058878N1
IRCT20230722058878N1
Recruiting
Phase 3

Investigating and comparing the therapeutic effect of Nevazin and vitamin B1 in chemotherapy-induced neuropathy in cancer patients undergoing chemotherapy

Qazvin University of Medical Sciences0 sites54 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Qazvin University of Medical Sciences
Enrollment
54
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • All cancer patients who are undergoing chemotherapy

Exclusion Criteria

  • People who are allergic to medicines containing vitamin B
  • use of other drugs effective in improving neuropathy such as Gabapentin, Pregavalin, Duloxetine

Outcomes

Primary Outcomes

Not specified

Similar Trials